Results 181 to 190 of about 811,687 (352)
POSTER VIEWING SESSION - REPRODUCTIVE ENDOCRINOLOGY [PDF]
, 2011 Mehmet Cengiz Çolakoğlu, H. Toy, Mehmet Sait İçen, Mehmet Vural, Ahmed S. Mahmoud, Fatih Yazici, N. Buendgen, Timothy M. Cordes, A. Schultze-Mosgau, K. Diedrich, Douglas Beyer, Georg Griesinger, E. J. Oude Loohuis, Marleen Nahuis, N. Bayram, P. G. A. Hompes, G. J. E. Oosterhuis, Peter Bossuyt, Fulco van der Veen, B. W. J. Mol, Madelon van Wely, Marleen Nahuis, E. J. Oude Loohuis, N. Kose, N. Bayram, P. G. A. Hompes, G. J. E. Oosterhuis, Peter Bossuyt, Fulco van der Veen, B. W. J. Mol, Madelon van Wely, Aylin Yaba, N. Demir, Alessandro Allegra, Abdul Harris Pane, A Marino, P Scaglione, Giovanni Ruvolo, Michelle Manno, Aldo Volpes, F. Lunger, L. Wildt, Beata Seeber, Efstratios M. Κolibianakis, Christos Venetis, J. Bosdou, Konstantinos A. Toulis, Dimitrios G. Goulis, Theoni B Tarlatzi, Basil C. Tarlatzis, Martin Franz, C Keck, S. Daube, Dorothy Pietrowski, N. Demir, Aylin Yaba, R. Iannetta, R. D. S. Santos, T. P. Lima, F. Giolo, Odilon Iannetta, Wellington P. Martins, Francisco José Albuquerque de Paula, Rui Alberto Ferriani, A. C. J. S. Rosa e Silva, Carlos Eduardo Martinelli, Rui Manuel Reis, Marta Devesa, Inmaculada Rodríguez, Buenaventura Coroleu, Rosa Tur, C. Gonzalez, Pedro N. Barri, Luciano G. Nardo, Lamiya Mohiyiddeen, Betselot Mulugeta, Helen McBurney, S. A. Roberts, William G. Newman, Marcin Grynberg, F. Lamazou, Maxime Even, V. Gallot, R Frydman, Rénato Fanchin, H. Abdalla, James Nicopoullos, Alexandra Leader, Seung-Ki Pang, Han Witjes, Kayla Gordon, Paul Devroey, C. Arrivi, A. P. Ferraretti, Maria Cristina Magli, M. L. Tartaglia, M. C. Fasolino, Luca Gianaroli, M Mácek, P. Feldmár +99 moreopenalex +1 more sourceEfficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double‐Blind, Phase 3 Trial in China
Arthritis &Rheumatology, EarlyView.Objective
Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of dotinurad with febuxostat in Chinese patients with gout. Methods
This phase 3, multicenter, randomized, double‐blind, parallel‐group study randomly allocated (1:1) eligible patients with gout to receive oral dotinurad ...Jia Sun, Yu Wang, Yongjing Cheng, Dongmei Guo, Jiankang Hu, Dongzhou Liu, Zhengnan Gao, Changgui Li, Yibing Lu, Xiaodan Kong, Yu Liu, Zhenyu Jiang, Bin Yi, Hongfeng Zhang, Baijie Xu, Shihao Yu, Rieko Kokan, Kohei Ishikawa, Mikiko Kawakatsu, Zhuoli Zhang +19 morewiley +1 more sourceAMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.
Endocrine Practice, 2016 H. Gharib, E. Papini, J. Garber, D. Duick, R. Mack Harrell, L. Hegedüs, R. Paschke, R. Valcavi, P. Vitti +8 moresemanticscholar +1 more sourceEfficacy and Safety of ABBV‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial
Arthritis &Rheumatology, EarlyView.Objective
Despite the availability of biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.Frank Buttgereit, Atul Singhal, Alan Kivitz, Edit Drescher, Yoshinori Taniguchi, Rosalía Martínez Pérez, Jaclyn Anderson, Ronilda D'Cunha, Weihan Zhao, Nicholas DeVogel, Julie Parmentier, Romy Christmann, Dilek Arikan, Howard Amital +13 morewiley +1 more source
